MedPath

SERC - TAB 4MG

SERC - TAB 4MG

Discontinued
DIN Number

02222035

Drug Class

Human

Market Date

Aug 13, 1997

Company
HC

solvay pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02222035
AIG Number0103555001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07CA01 BETAHISTINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BETAHISTINE HYDROCHLORIDEActive
Strength: 4 MG / TAB
Monograph: BETAHISTINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.